# Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19

> **NCT04751604** · NA · COMPLETED · sponsor: **University Hospital Schleswig-Holstein** · enrollment: 900 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04751604
- **Lead sponsor:** University Hospital Schleswig-Holstein
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-07-27
- **Final completion:** 2022-10-20
- **Target enrollment:** 900 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04751604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04751604, "Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04751604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*